VIVA and VEINS 2023: Late-Breaking Video Collection
Published: 27 November 2023
-
Views:
485
-
Likes:
7
-
Views:
485
-
Likes:
7
-
Up Next -
10m 22sPart 1 | Session 4 Wearable Non-Invasive Ultrasound for CLTI -
10m 41sPart 1 | Session 5 STRIKE-PE: Indigo Aspiration System for PE -
6m 40sPart 1 | Session 6 PROMISE II: 12M Results From Pivotal Trial of LimFlow System
-
4m 2sPart 1 | Session 1 SAVER: Gender Subgroup Analysis Marianne Brodmann
-
7m 2sPart 1 | Session 2 VIVID: Venous Stent for the Iliofemoral Vein Mahmood K Razavi
Overview
Short, accessible Expert Interviews will be available with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Part 1
Expert Interviews
About the episode
VIVA 23 - We are joined virtually by Dr Sean Lyden (Cleveland Clinic, US) to discuss the findings of a pooled analysis of the DETOUR1 and DETOUR2 studies, which clinically investigated a device intended to improve blood flow in patients with peripheral arterial disease due to femoropopliteal chronic total occlusions.
Results suggest that at 2 years, the PQ bypass system is a safe and effective percutaneous treatment option for patients with longer, severely calcified lesions.
Interview Questions:
- What are the unmet needs for PAD patients with symptomatic femoropoliteal chronic total occlusions?
- Could you tell us about the unique features of the PQ Bypass System?
- What was the study design and patient population?
- What were the key results?
- What are your take-home messages?
- What further study is needed?
Recorded remotely from Ohio, 2023.
Editor: Jordan Rance
Video Specialist: Oliver Miles
Faculty Biographies
Sean Lyden
Chairman of the Department of Vascular Surgery
Dr Sean Lyden is the Chairman of the Department of Vascular Surgery at Cleveland Clinic’s Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute.
Dr Lyden earned his medical degree from the University of Cincinnati College of Medicine following an undergraduate degree from the University of Notre Dame. He served a residency in general surgery at the University of Tennessee Health Sciences Center in Memphis where he was inducted into the Alpha Omega Alpha Medical Honor Society. His training included a year doing trauma research. He subsequently served a fellowship in vascular surgery at the University of Rochester-Strong Memorial Hospital, Rochester, NY.
Dr Lyden performs more than 200 procedures each year. His specialty interests include failed endovascular aneurysm repair, drug coated balloon use in arterial disease, popliteal artery entrapment syndrome.
Currently, he is involved in clinical trials studying various topics including…
Comments